Resistance to infection by the facultative intracellular bacterium Listeria monocytogenes is mediated by T lymphocytes (1, 2) . The response of T cells is antigen specific and results in the activation of the microbicidal activity of macrophages (3, 4) . IFNy and other lymphokines produced by T cells appear to be involved in this activation of macrophages (5) .
Results
Effect of In Vivo Administration of Anti-L3T4 (CD4) nzAb and/or Anti-Lyt-2.2 (CD8) mAb on Multiplication and Clearance ofBacteria, and Liver Cell Necrosis in Sublethal Listeriosis. Injection of 10 3 CFU of L. monocytogenes into BALB/c mice caused sublethal listeriosis. To determine the roles of T cell subsets in primary sublethal listeriosis, we examined the effect of in vivo administration of anti-L3T4 (CD4) mAb, antiLyt-2.2 (CD8) mAb, and a combination of both mAbs on the multiplication and clearance of the bacteria and liver cell necrosis . The injections of anti-L3T4 (CD4) mAb and anti-Lyt-2 .2 (CD8) mAb caused selective depletions of CD4+ cells and CD8+ cells, respectively (see Materials and Methods) . As shown in Fig. 1 , the number of bacteria recovered from the liver and spleen of the infected mice treated with MEM (control) reached a peak of -105 CFU on days 2-4 and then decreased to an undetectable level by day 10 . Treatment of mice with anti-L3T4 (CD4) mAb increased the peak number of the bacteria, whereas treatment with anti-Lyt-2 .2 (CD8) mAb or a combination of the two mAbs decreased the peak number.
Treatment of mice with anti-L3T4 (CD4) or anti-Lyt-2 .2 (CD8) mAb resulted in clearance of the bacteria, although this was delayed, but treatment with a combination of the two mAbs blocked bacterial clearance. These results indicated that either CD4+ or CD8+ cells were necessary for, and capable of, mediating clearance of the bacteria . As the delay of bacterial clearance was significantly greater after treatment with anti-Lyt-2 .2 (CD8) mAb than after treatment with anti-L3T4 (CD4) mAb, Effects of in vivo administration of anti-L3T4 (CD4) mAb (*), anti-Lyt-2 .2 (CD8) mAb (A), or a combination of both mAbs (0) on recovery of bacteria from the liver (A) and spleen (B) . (O) MEM control . Female BALB/c mice were injected intravenously with 103 CFU of L. monocytogenes on day 0, anti-L3T4 (CD4) mAb on days -1, 13, 27, and 41, and anti-Lyt-2 .2 (CD8) mAb on days -1 and 27 . The number of Listeria recovered from organs of infected mice on the indicated days was determined by colony formation assay on TSA . Values are means t SD for groups of three to seven mice and means for groups of two mice. The detection limit was 1 Log Listeria . CD8+ cells may be more efficient than CD4+ cells in mediating clearance of bacteria in sublethal listeriosis.
Serum GOT and GPT are parenchymal cell enzymes commonly used as markers of liver cell necrosis . The serum transaminase levels were slightly elevated (GOT, <200 U/ml; GPT, <100 U/ml) in mice treated with MEM (control) after injection of 103 CFU of Listeria (Fig . 2) . Treatment of mice with anti-L3T4 (CD4) mAb increased the peak levels further, whereas treatment with anti-Lyt-2.2 (CD8) mAb or both mAbs lowered the levels slightly. Histological examination of the liver on day 4 showed multiple necrotic foci in mice treated with MEM (Fig . 3 A) and larger and more numerous necrotic foci in mice treated with anti-L3T4 (CD4) mAb.
The increases in the peak number of bacteria recovered from the liver and spleen, and in the levels ofserum transaminases in mice treated with anti-L3T4 (CD4) mAb, were studied further using different sized inocula ofListeria for infection. As shown in Tables I and II, these increases were even clearer in mice infected with a larger number of bacteria (1.6 x 103 CFU), but were not observed in mice infected with fewer bacteria (4 x 10 2 CFU) . Photomicrographs of the liver in listeriosis. Specimens were obtained on day 4 from a mouse inoculated with a sublethal dose (103 CFU) (A), and on day 3 from a mouse inoculated with a lethal dose (7 x 10 3 CFU) (B) of Listeria, and on day 14 from a mouse inoculated with a lethal dose and rMuIFN-.y on day 0 (C). H-E, x 40 . Multiple necrotic foci (arrows) are observed in A, multiple small abscesses (stained dark) containing bacterial clusters and neutrophils in diffusely necrotic liver are seen in B, and no obvious necrotic foci can be seen in C.
Effect of In Vivo Administration of Anti-L3T4 (CD4) mAb and/or Anti-Lyt-2.2 (CD8) mAb on Mortality, Bacterial Multiplication, and Liver Cell Necrosis in Lethal Listeriosis. Injection of >7 x 103 CFU of L. monocytogenes into BALB/c mice caused lethal listeriosis; the mice died after 4-8 d from systemic infection and massive liver necrosis . We investigated the effect of in vivo administration of anti-L3T4 (CD4) mAb and/or anti-Lyt-2 .2 (CD8) mAb on survival of these mice with lethal listeriosis (Fig. 4) . Treatment with anti-L3T4 (CD4) mAb did not prolong survival significantly, but treatment with anti-Lyt-2 .2 (CD8) mAb, or a combination of both mAbs, prolonged survival markedly.
The effects of these mAbs on multiplication of bacteria in lethal listeriosis were then investigated . After treatment of mice with MEM (control) or anti-L3T4 (CD4) mAb, the recovery of bacteria increased exponentially in the liver and spleen resulting in death, whereas after treatment with anti-Lyt-2 .2 (CD8) mAb or a combination of both mAbs, the recovery of bacteria increased to a peak of -10' CFU on day 3 and then decreased (Fig . 5) . Treatment of mice with anti-Lyt-2 .2 (CD8) mAb resulted in clearance of the bacteria by day 40, whereas after treatment with a combination of the two mAbs, the mice remained persistently infected and -103 -104 CFU of bacteria were recovered from the liver and spleen for up to at least 60 d (data not shown) .
Increases in the serum levels of transaminases (GOT, >500 U/ml ; GPT, >150 U/ml) were observed as early as day 2 in all mice treated with MEM (control) or mAb ( Fig . 6 ) . After treatment with MEM (control) or anti-L3T4 (CD4) mAb, the levels of serum transaminases increased continuously until death, whereas after treatment with anti-Lyt-2 .2 (CD8) mAb or a combination of the two mAbs, the levels of serum transaminases increased to a peak on day 3, and then decreased to within the normal range by day 14 . Histopathological examination of the liver showed massive necrosis on day 3 in mice treated with MEM ( Fig . 3 B) or anti-L3T4 (CD4) mAb. In mice treated with anti-Lyt-2 .2 (CD8) or a combination of the two mAbs, moderate liver necrosis was observed on day 3 followed by recovery by day 14 . These results suggested that CD8 + cells played a role in irreversible multiplication of the bacteria and massive liver necrosis, which causes death in lethal listeriosis. Adoptive transfer experiments with nude mouse recipients were performed to confirm this point. Transfer of spleen cells from normal BALB/c mice pretreated with anti-L3T4 (CD4) mAb and complement, but not anti-Lyt-2 .2 (CD8) mAb and complement, killed recipient BALB/c nu/nu mice inoculated with 104 CFU of bacteria (Fig . 7) . Effect of In Vivo Administration of rMuIFN-y on Mortality, Bacterial Multiplication, and Liver Cell Necrosis in Lethal Listeriosis. In mice with lethal listeriosis that were untreated or had been pretreated with anti-L3T4 (CD4) mAb, injection of rMuIFN-y (3 x 104 U/mouse, i.v.) resulted in marked prolongation of survival (Table III and Fig. 8 ), decrease in multiplication of bacteria (Fig . 9) , and restoration of transaminase levels to normal (Fig . 10) . Histological examination showed recovery from necrosis in the liver of mice on day 7 after treatment with either MEM (Fig . 3 C) or anti-L3T4 (CD4) mAb and rMuIFN-y . 
Discussion
In this study, we found that in mice with sublethal listeriosis, CD8+ cells augmented the peak recovery of bacteria and the extent of liver cell necrosis, and CD4+ cells suppressed this CD8 + cell-mediated augmentation . Treatment of mice with anti-CD4 mAb increased the peak recovery of bacteria and the levels of serum transaminases, whereas treatment with anti-CD8 mAb or a combination of the two mAbs had the reverse effects. These effects were evident in mice treated with higher doses (0 .8-16 x 10 3 ) of bacteria . In mice treated with a combination of the two mAbs, the liver and spleen remained persistently infected (102 -104 CFU/organ) after the initial decrease in the bacterial recovery. Since persistent infection was also observed in BALB/c nu/nu mice inoculated with a sublethal dose of Listeria (unpublished results and reference 16), the mechanism(s) of resistance to Listeria multiplication in the persistent infection appears to be T cell independent. In fact, macrophage-mediated protection against Listeria was shown to be effective to a significant extent in euthymic mice as well as in nude mice (16) . For complete clearance of bacteria, however, T cells are definitely required (1, 2, 16, and this paper) . We demonstrated that either CD4+ or CD8+ cells were necessary for, and capable of, mediating clearance of the bacteria. CD8+ cells were more efficient than CD4`cells, but for optimal clearance both were necessary.
It has been controversial whether CD4+ cells or CD8+ cells are responsible for protection against Listeria . Previous studies on adoptive transfer of lymphocytes from immune mice to naive recipients showed that both CD4+ and CD8+ cells were required for resistance to Listeria (7) (8) (9) (10) (11) . However, when larger numbers of lymphocytes were transferred, CD8+ cells were sufficient for protection (11) . Recently, (14) showed that in vivo administration of anti-L3T4 (CD4) mAb to mice resulted in increased recovery of bacteria and exacerbation of liver necrosis early (day 3) after inoculation of a sublethal dose of Listeria . Thus, they concluded that CD4' cells were essential for protection . The present findings in kinetic analyses of bacterial recovery and the levels of serum transaminases were consistent with all these results and revealed that these findings are not conflicting, but rather reflected different phases during the course of infection, We also demonstrated that in lethal listeriosis, treatment of mice with anti-CD8 mAb, or a combination of anti-CD4 and anti-CD8 mAbs, but not anti-CD4 mAb alone, markedly prolonged survival, and resulted in decrease in recovery of bacteria after a peak of -108 CFU and in a decrease in the levels of serum transaminases. These findings indicated that CD8+ cells were responsible for irreversible multiplication of the bacteria and severe liver necrosis causing death in lethal listeriosis . In this regard, it is noteworthy that 95% of an intravenous inoculum of Listeria is cleared by the liver and that hepatocytes, rather than macrophages, are the main targets of Listeria in the liver (15) . Hepatocytes are incapable of inactivating the bacteria intracellularly (15) . Our results are consistent with the findings that Listeria-specific CD8+ CTL are generated from spleen cells derived from infected mice (22) . During the course of viral infection, CD8 + CTL are generated against virally infected target cells, and these CTL have been shown to be important for antiviral defense (23) . However, it is unknown whether the liver damage by CD8+ cells observed in sublethal and lethal listerial infection represents a relevant mechanism of antibacterial resistance . The effects of administration of anti-CD4 and anti-CD8 mAbs were evident as early as day 2 after primary sublethal or lethal infection with Listeria . These findings indicated early involvement of T cells in host defense against primary listeriosis and are consistent with the findings previously described (2) .
We found that administration of rMuIFN-y to mice with lethal listeriosis markedly prolonged survival, and resulted in a decrease in the multiplication of bacteria and in recovery from liver necrosis in mice treated with either MEM or anti-CD4 mAb. These findings are consistent with previous reports of decreased bacterial recovery after administration of rMuIFN-y (24) and the requirement of endogenous IFN-y for recovery from Listeria infection (25, 26) . The mechanism(s) by which IFN-y protects mice against lethal listeriosis is unknown, but several possibilities may be considered . First, exogenously administered rIFN-y may decrease the multiplication of bacteria by activating macrophages, subsequently resulting in recovery from liver cell necrosis . This possibility is consistent with reports that IFN-y activates macrophages to promote antimicrobial activity in vitro (27, 28) and in vivo (24) , and that macrophages ingest and inactivate Listeria (15, 29) , rather than supporting its growth, as has been generally assumed (15) . Second, IFN-' r may exert its effect by binding to surface receptors and inducing intracellular changes that are unfavorable for development of Listeria . This possibility is supported by reports that receptors for IFN-y are present on various cells, includinghepatocytes (30) , and that IFN-'r induces phenotypic and functional alterations (31) . Indeed, this mechanism has re-T CELLS AND RECOMBINANT INTERFERON -y IN LISTERIOSic cently been shown to operate in hepatocytes with malaria parasites (30) . These two mechanisms are not mutually exclusive and could occur simultaneously. Third, IFN-y may inhibit CD8' cell-mediated cytotoxicity. However, since IFN-' r has so far been regarded as an essential lymphokine for the proliferation and differentiation of cytotoxic T lymphocytes (32, 33) , this possibility seems unlikely. Summary Studies were made on the effects of in vivo administration of anti-CD4 mAb, anti-CD8 mAb, or a combination ofboth mAbs on multiplication of bacteria, the levels of serum transaminases, and mortality in mice infected with Listeria monocytogenes . Results showed that in sublethal infection, CD8 + cells enhanced the peak of bacterial multiplication and liver cell necrosis, and CD4+ cells suppressed CD8 + cell-mediated enhancement . Results also showed that either CD4 + or CD8 + cells were necessary for, and capable of, mediating clearance of the bacteria. CD8 + cells were more efficient than CD4+ cells, but for optimal clearance both were necessary.
In lethal listeriosis, treatment of mice with anti-CD8 mAb or a combination of both anti-CD4 and anti-CD8 mAbs, but not anti-CD4 mAb only, protected mice from death by decreasing multiplication of bacteria in the liver and spleen after a peak of -10 1 CFU, and lowering the elevated serum levels of transaminases . These findings indicated that CD8 + cells were responsible for causing irreversible systemic Listeria infection and severe liver necrosis.
In lethal listeriosis, administration of rMuIFN-y markedly prolonged survival by decreasing multiplication of bacteria and promoting recovery from liver necrosis.
